Our OEM partners
Aerogen collaborates with leading medical device companies worldwide. Each partner works with us to bring proven, reliable aerosol drug delivery to clinicians and patients.
Delivering reliable aerosol therapy
Breathe easy with
Aerogen inside your device
Aerogen delivers integrated aerosol drug delivery technology for ventilators, high-flow therapy systems and respiratory support devices worldwide. Designed for seamless incorporation into mechanical ventilation platforms, our systems support aerosol therapy during invasive and non-invasive ventilation without interrupting respiratory support.1
By collaborating with leading medical device manufacturers, Aerogen enables healthcare providers to deliver effective and optimised aerosol therapy across intensive care units, emergency departments and acute respiratory settings.1
Aerogen sets the standard in aerosol drug delivery: We understand the regulatory landscape, mandates, and international standards so that we can support you with expertise. With a presence in more than 80 countries and over 300 publications, Aerogen represents excellence.*2
Accelerates your platform development: Leverage decades of proven R&D capability, deep regulatory insight, and over 300 patents to seamlessly integrate world-class aerosol drug delivery into your devices.*2
25+ years of aerosol expertise de-risks your regulatory pathway: We partner with your regulatory teams to navigate compliance and submissions.*2
Answers on demand: Our AeroEd Learning Management System and clinical educators support your customers in optimising aerosol delivery across every patient scenario.
At the cutting edge: Regular clinical and business updates keep you at the forefront of aerosol delivery science. Aerogen continually conducts scientific and clinical research in collaboration with global key opinion leaders, leading institutions, pharmaceutical and medical device partners.
Industry leading credibility strengthens your position: The Aerogen brand is synonymous with innovative closed ventilation circuit aerosol drug delivery and uncompromising quality standards across different care settings.1-4 Over 30 million patients worldwide have benefitted from our high-performance vibrating mesh nebuliser technology for aerosol delivery.2 Our complaint rate of 0.003% reflects the high satisfaction levels of our customers and partners and Aerogen has been recognised as a 12-time winner of the prestigious Zenith Award.2
